Deutsche Bank Ag\ Keros Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$262 Billion
Q2 2025

A detailed history of Deutsche Bank Ag\ transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 211,637 shares of KROS stock, worth $2.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

211,637

Previous 22,962 821.68%

Holding current value

$2.9 Million

Previous $233,000 1112.45%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$9.55 - $15.11 $1.8 Million - $2.85 Million	188,675 Added 821.68%	211,637 $2.83 Million
Q1 2025 May 09, 2025	SELL	$10.15 - $16.1 $40,549 - $64,319	-3,995 Reduced 14.82%	22,962 $233,000
Q4 2024 Jun 30, 2025	BUY	$15.64 - $70.0 $62,481 - $279,650	3,995 Added 17.4%	26,957 $426,000
Q4 2024 Feb 14, 2025	BUY	$15.64 - $70.0 $132,111 - $591,290	8,447 Added 45.63%	26,957 $426,000
Q3 2024 Jun 26, 2025	SELL	$41.68 - $58.07 $185,559 - $258,527	-4,452 Reduced 19.39%	18,510 $1.07 Million
Q3 2024 Nov 13, 2024	SELL	$41.68 - $58.07 $4.4 Million - $6.13 Million	-105,603 Reduced 85.09%	18,510 $1.07 Million
Q2 2024 Jun 12, 2025	BUY	$44.58 - $66.89 $4.51 Million - $6.77 Million	101,151 Added 440.51%	124,113 $5.67 Million
Q2 2024 Aug 14, 2024	BUY	$44.58 - $66.89 $1,827 - $2,742	41 Added 0.03%	124,113 $5.67 Million
Q1 2024 Jun 02, 2025	BUY	$41.26 - $70.48 $4.17 Million - $7.13 Million	101,110 Added 440.34%	124,072 $8.21 Million
Q1 2024 May 15, 2024	SELL	$41.26 - $70.48 $9.66 Million - $16.5 Million	-234,204 Reduced 65.37%	124,072 $8.21 Million
Q4 2023 Feb 14, 2024	BUY	$27.12 - $41.05 $9.38 Million - $14.2 Million	345,704 Added 2749.79%	358,276 $14.2 Million
Q3 2023 Nov 09, 2023	SELL	$31.57 - $43.02 $2.22 Million - $3.03 Million	-70,319 Reduced 84.83%	12,572 $400,000
Q2 2023 Aug 14, 2023	SELL	$37.26 - $51.01 $167,856 - $229,800	-4,505 Reduced 5.15%	82,891 $3.33 Million
Q1 2023 May 15, 2023	BUY	$41.44 - $59.32 $3.15 Million - $4.51 Million	75,946 Added 663.28%	87,396 $3.73 Million
Q4 2022 Feb 13, 2023	BUY	$39.45 - $51.77 $134,366 - $176,328	3,406 Added 42.34%	11,450 $549,000
Q3 2022 Nov 14, 2022	SELL	$27.8 - $40.12 $62,021 - $89,507	-2,231 Reduced 21.71%	8,044 $303,000
Q2 2022 Aug 11, 2022	BUY	$26.03 - $67.04 $3,514 - $9,050	135 Added 1.33%	10,275 $285,000
Q1 2022 May 13, 2022	SELL	$42.12 - $59.36 $42,372 - $59,716	-1,006 Reduced 9.03%	10,140 $552,000
Q4 2021 Feb 11, 2022	BUY	$36.95 - $62.89 $13,634 - $23,206	369 Added 3.42%	11,146 $652,000
Q3 2021 Nov 04, 2021	SELL	$29.27 - $43.71 $8,400 - $12,544	-287 Reduced 2.59%	10,777 $427,000
Q2 2021 Aug 11, 2021	BUY	$42.4 - $70.11 $59,868 - $98,995	1,412 Added 14.63%	11,064 $469,000
Q1 2021 May 13, 2021	SELL	$54.0 - $75.28 $42,768 - $59,621	-792 Reduced 7.58%	9,652 $594,000
Q4 2020 Feb 16, 2021	BUY	$36.0 - $82.74 $237,312 - $545,422	6,592 Added 171.13%	10,444 $736,000
Q3 2020 Nov 12, 2020	BUY	$27.04 - $62.21 $9,085 - $20,902	336 Added 9.56%	3,852 $149,000
Q2 2020 Aug 13, 2020	BUY	$20.08 - $40.39 $70,601 - $142,011	3,516 New	3,516 $132,000

Others Institutions Holding KROS

# of Institutions

156

Shares Held

38.6M

Call Options Held

834K

Put Options Held

969K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $353M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account